New senior vice-president at Cellectis
This article was originally published in Scrip
Executive Summary
Cellectis, the French specialist in genome engineering specialist, has appointed Dr Mathieu Simon to the position of senior vice-president. He will be in charge of developing therapeutic and new commercial activities, including launching innovative products. Dr Simon was previously senior vice-president of pharma global operations for Groupe Pierre Fabre Medicament, and has also worked for Wyeth in the US and France.